Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins.

Publications show all

Molecular Partners has published 9 articles.

Patents show all

65Applications24Issued

Clinical Trials show all

3Phase 12Phase 1/Phase 2